Home » Stocks » FENC

Fennec Pharmaceuticals Inc. (FENC)

Stock Price: $7.43 USD 0.04 (0.54%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 190.03M
Revenue (ttm) n/a
Net Income (ttm) -18.48M
Shares Out 25.60M
EPS (ttm) -0.83
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $7.43
Previous Close $7.39
Change ($) 0.04
Change (%) 0.54%
Day's Open 7.44
Day's Range 7.25 - 7.57
Day's Volume 109,434
52-Week Range 4.89 - 10.17

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 2 months ago

~ The Company Continues to Work with the FDA and Its Third-Party Drug Product Manufacturer to Fully Address CRL and Prepare NDA Resubmission for PEDMARK™  ~

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - November 2, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fennec Pharmaceuticals Inc. (NA...

PRNewsWire - 2 months ago

NEW YORK, Nov. 2, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. between February 11, 2020 and Augu...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - November 2, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - November 2, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fennec Pharmaceuticals Inc. (...

Newsfile Corp - 2 months ago

Los Angeles, California--(Newsfile Corp. - November 2, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fenne...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - October 30, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) ...

Business Wire - 2 months ago

LOS ANGELES--(BUSINESS WIRE)---- $FENC #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming November 2, 2020 deadline to file a lead plaintiff motion in the class a...

Business Wire - 2 months ago

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NAS...

Newsfile Corp - 2 months ago

Los Angeles, California--(Newsfile Corp. - October 30, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fennec...

PRNewsWire - 2 months ago

LOS ANGELES, Oct. 29, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Middle District of No...

Newsfile Corp - 2 months ago

Los Angeles, California--(Newsfile Corp. - October 29, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fennec...

Business Wire - 2 months ago

NEW YORK--(BUSINESS WIRE)-- #Fennec--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the Unite...

PRNewsWire - 2 months ago

NEW YORK, Oct. 28, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between February 1...

PRNewsWire - 2 months ago

BENSALEM, Pa., Oct. 28, 2020 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming November 2, 2020 deadline to file a lead plaintiff motion in the class action file...

Newsfile Corp - 2 months ago

Los Angeles, California--(Newsfile Corp. - October 28, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fennec...

PRNewsWire - 2 months ago

LOS ANGELES, Oct. 27, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming November 2, 2020 deadline to file a lead plaintiff motion in the class action f...

Newsfile Corp - 2 months ago

Los Angeles, California--(Newsfile Corp. - October 27, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fennec...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - October 23, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC)...

PRNewsWire - 3 months ago

NEW YORK, Oct. 14, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities c...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - October 12, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) ...

PRNewsWire - 3 months ago

NEW YORK, Oct. 9, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between February 11...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - October 7, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securi...

Business Wire - 3 months ago

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NAS...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - October 5, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) b...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - September 28, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FEN...

PRNewsWire - 3 months ago

LOS ANGELES, Sept. 25, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Middle District of N...

GlobeNewsWire - 3 months ago

RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (Nasdaq: FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMAR...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - September 20, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc.

PRNewsWire - 4 months ago

LOS ANGELES, Sept. 17, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming November 2, 2020 deadline to file a lead plaintiff motion in the class action ...

Business Wire - 4 months ago

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that a class action lawsuit has been filed in the Middle District of North Carolina on behalf of purchasers of Fennec Pha...

PRNewsWire - 4 months ago

NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Fennec P...

Newsfile Corp - 4 months ago

New York, New York--(Newsfile Corp. - September 12, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc.

Newsfile Corp - 4 months ago

New York, New York--(Newsfile Corp. - September 11, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fennec Pharmaceuticals Inc.

Business Wire - 4 months ago

BENSALEM, Pa.--(BUSINESS WIRE)---- $FENC #classaction--Deadline Reminder:Law Offices of Howard G.

Newsfile Corp - 4 months ago

New York, New York--(Newsfile Corp. - September 11, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Fennec Pharmaceuticals Inc.

Business Wire - 4 months ago

NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or...

Business Wire - 4 months ago

LOS ANGELES--(BUSINESS WIRE)---- $FENC #FENC--SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc.

Business Wire - 4 months ago

BENSALEM, Pa.--(BUSINESS WIRE)---- $FENC #classaction--INVESTOR ALERT: Law Offices of Howard G.

Newsfile Corp - 4 months ago

New York, New York--(Newsfile Corp. - September 7, 2020) - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the sec...

Business Wire - 4 months ago

NEW YORK--(BUSINESS WIRE)---- $FENC #classaction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of...

Business Wire - 4 months ago

LOS ANGELES--(BUSINESS WIRE)---- $FENC #FENC--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc.

Business Wire - 4 months ago

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Fennec Pharmaceuticals...

Business Wire - 4 months ago

LOS ANGELES--(BUSINESS WIRE)---- $FENC #classaction--The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Middle Dist...

Business Wire - 4 months ago

LOS ANGELES--(BUSINESS WIRE)--FENC CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Fennec Pharmaceuticals Inc.

Business Wire - 4 months ago

BENSALEM, Pa.--(BUSINESS WIRE)---- $FENC #fraud--INVESTOR ALERT: Law Offices of Howard G.

Business Wire - 4 months ago

LOS ANGELES--(BUSINESS WIRE)---- $FENC #classaction--The Law Offices of Frank R. Cruz continues its investigation on behalf of Fennec Pharmaceuticals Inc.

Business Wire - 4 months ago

LOS ANGELES--(BUSINESS WIRE)---- $FENC #fraud--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Fennec Pharmaceuticals Inc. on Behalf of Investors

Business Wire - 4 months ago

NEW YORK--(BUSINESS WIRE)---- $FENC #classaction--The law firm of Kirby McInerney LLP is investigating potential claims against Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NASDAQ:...

Business Wire - 4 months ago

NEW YORK--(BUSINESS WIRE)-- #FENC--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fennec Pharmaceuticals, Inc.

About FENC

Fennec Pharmaceuticals, a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, ... [Read more...]

Industry
Biotechnology
IPO Date
Jun 5, 2001
CEO
Rostislav Raykov
Employees
4
Stock Exchange
NASDAQ
Ticker Symbol
FENC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for FENC stock is "Strong Buy." The 12-month stock price forecast is 15.00, which is an increase of 101.88% from the latest price.

Price Target
$15.00
(101.88% upside)
Analyst Consensus: Strong Buy